* LivaNova PLC LIVN.OQ reported quarterly adjusted
earnings of
73 cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 43
cents. The mean expectation of eight analysts for the quarter
was for earnings of 49 cents per share. Wall Street expected
results to range from 43 cents to 53 cents per share.
* Revenue rose 12% to $294.90 million from a year ago;
analysts
expected $278.66 million.
* LivaNova PLC's reported EPS for the quarter was a loss
of 78
cents.
* The company reported a quarterly loss of $41.9 million.
* LivaNova PLC shares had fallen by 0.3% this quarter and
gained 7.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 13.3%
in the last three months.
* In the last 30 days, two analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for LivaNova PLC is
$65.00
This summary was machine generated from LSEG data May 1 at 12:22
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.49 0.73 Beat
Dec. 31 2023 0.77 0.87 Beat
Sep. 30 2023 0.64 0.73 Beat
Jun. 30 2023 0.54 0.78 Beat